Julie Schneider, MD
Urogynecology and Reconstructive Pelvic Surgery · Ormond Beach, FLNPI 1720001852
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 93.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $4,767 and has fallen 86.8% since, to $630 in 2025.
Across 99 payments — averaging $68.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Stryker$167
- Axonics, Inc.$135
- Astellas Pharma US Inc$85
- AbbVie$19
- Chiesi USA, Inc.$17
- plus $41 from 3 others
Across 1 payment — averaging $532.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$533
What the payments were for
- Consulting fees$4056%
- Speaking & faculty fees$4,00059%
- Food & beverage$2,29134%
- Education$851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 88 | $6,317 |
| Stryker | 1 | $167 |
| Axonics, Inc. | 4 | $135 |
| Astellas Pharma US Inc | 1 | $85 |
| AbbVie | 1 | $19 |
| Chiesi USA, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Dysis Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,781 in reported general payments places this provider in the 55th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 275 | $246,041 |
| MyrbetriqMirabegron | 151 | $105,681 |
| Estradiol | 174 | $9,436 |
| Trospium Chloride | 155 | $7,823 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 550 | $5,895 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 203 | $1,146 |
| Clobetasol Propionate | 31 | $980 |
| Levofloxacin | 191 | $576 |
| Cefpodoxime Proxetil | 11 | $394 |
| Amoxicillin | 63 | $178 |
| Oxybutynin Chloride | 14 | $164 |
| Fluconazole | 33 | $164 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 40 | $141 |
| Tramadol Hcl | 23 | $51 |
| Ciprofloxacin Hcl | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $85 | $105,681151 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Ormond Beach
- Nathan KowOrlando$116K
- Amir ShariatiCoconut Creek$106K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Arash RahiCoconut Creek$23K
- Moises VirellesWellington$21K
- Marja SprockRockledge$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.